Increase lymphocyte infiltration overcomes tumor resistance to checkpoint blockade

被引：0
作者：
Tang, Haidong [1 ]
Wang, Yang [1 ]
Fu, Yang-Xin [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR15-A088
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A088
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade.
    Lander, Varintra E.
    Belle, Jad I.
    Knolhoff, Brett L.
    Herndon, John M.
    Mpoy, Cedric
    Rogers, Buck E.
    Schwarz, Julie K.
    DeNardo, David G.
    CANCER RESEARCH, 2021, 81 (22) : 76 - 77
  • [32] DUAL TARGETING OF IL-6 AND CD40 OVERCOMES GLIOBLASTOMA RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE
    Yang, Fan
    Brem, Steven
    Fan, Yi
    NEURO-ONCOLOGY, 2020, 22 : 107 - 107
  • [33] Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients
    Twyman-Saint Victor, Christina
    Rech, Andrew
    Benci, Joseph
    Maity, Amit
    Rengan, Ramesh
    Pauken, Kristen
    Stelekati, Erietta
    Xu, Bihui
    Dada, Hannah
    Odorizzi, Pamela
    Herati, Ramin
    Amaravadi, Ravi
    Schuchter, Lynn
    Ishwaran, Hemant
    Mick, Rosemarie
    Pryma, Daniel
    Xu, Xiaowei
    Feldman, Michael
    Gangadhar, Tara
    Hahn, Steve
    Wherry, John
    Vonderheide, Robert
    Minn, Andy
    CANCER RESEARCH, 2016, 76
  • [34] Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients
    Victor, Christina Twyman-Saint
    Rech, Andrew
    Maity, Amit
    Rengar, Ramesh
    Pauken, Kristen
    Stelekati, Erietta
    Benci, Joseph
    Xu, Bihui
    Dada, Hannah
    Odorizzi, Pamela
    Herati, Ramin
    Mansfield, Kathleen
    Patsch, Dana
    Amaravadi, Ravi
    Schuchter, Lynn
    Ishwaran, Hemant
    Mick, Rosemarie
    Pryma, Daniel
    Xu, Xiaowei
    Feldman, Michael
    Gangadhar, Tara
    Hahn, Stephen
    Wherry, E. John
    Vonderheide, Robert
    Minn, Andy
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [35] Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
    Benci, Joseph L.
    Xu, Bihui
    Qiu, Yu
    Wu, Tony J.
    Dada, Hannah
    Twyman-Saint Victor, Christina
    Cucolo, Lisa
    Lee, David S. M.
    Pauken, Kristen E.
    Huang, Alexander C.
    Gangadhar, Tara C.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Feldman, Michael D.
    Ishwaran, Hemant
    Vonderheide, Robert H.
    Maity, Amit
    Wherry, E. John
    Minn, Andy J.
    CELL, 2016, 167 (06) : 1540 - +
  • [36] SOX2 EXPRESSION IN NSCLC MEDIATES CHANGES IN THE TUMOR MICROENVIRONMENT IMPAIRING T CELL INFILTRATION AND PROMOTING RESISTANCE TO CHECKPOINT BLOCKADE THERAPY
    Spranger, Stefani
    Bhutkar, Arjun
    Nguyen, Kim
    Weng, Sally
    Duong, Ellen
    Blatt, Sarah
    Torres-Mejia, Elen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1524 - A1524
  • [37] Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
    Gauttier, Vanessa
    Pengam, Sabrina
    Durand, Justine
    Biteau, Kevin
    Mary, Caroline
    Morello, Aurore
    Neel, Melanie
    Porto, Georgia
    Teppaz, Geraldine
    Thepenier, Virginie
    Danger, Richard
    Vince, Nicolas
    Wilhelm, Emmanuelle
    Girault, Isabelle
    Abes, Riad
    Ruiz, Catherine
    Trilleaud, Charlene
    Ralph, Kerry
    Trombetta, E. Sergio
    Garcia, Alexandra
    Vignard, Virginie
    Martinet, Bernard
    Glemain, Alexandre
    Bruneau, Sarah
    Haspot, Fabienne
    Dehmani, Safa
    Duplouye, Pierre
    Miyasaka, Masayuki
    Labarriere, Nathalie
    Laplaud, David
    Le Bas-Bernardet, Stephanie
    Blanquart, Christophe
    Catros, Veronique
    Gouraud, Pierre-Antoine
    Archambeaud, Isabelle
    Auble, Helene
    Metairie, Sylvie
    Mosnier, Jean-Francois
    Costantini, Dominique
    Blancho, Gilles
    Conchon, Sophie
    Vanhove, Bernard
    Poirier, Nicolas
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (11) : 6109 - 6123
  • [38] LIGHTing tumor up for checkpoint blockade
    Liang, Yong
    Peng, Hua
    ONCOTARGET, 2016, 7 (31) : 48857 - 48858
  • [39] Negative selection of ligand-receptor interactions mediating lymphocyte infiltration confers melanoma resistance to Immune Checkpoint Blockade therapy by turning hot tumors to cold
    Sahni, Sahil
    Wang, Kun
    Wang, Binbin
    Dhruba, Saugato Rahman
    Wu, Di
    Nagy, Matthew
    Ruppin, Eytan
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [40] Cancer: Overcoming resistance to checkpoint blockade
    Crunkhorn S.
    Nature Reviews Drug Discovery, 2018, 17 (9) : 622 - 622
12345